Furthermore, CP-673451 treatment could also be of great benefit for tackling neurological disorders such as Alzheimer’s, Huntington’s and Parkinson’s diseases, in which DUSP1 dysregulation has been reported [38]. This evidence concerns the gene DUSP1 and nervous system disorder.